Teleflex Incorporated Signs New Three-Year Agreements with Novation

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced several new agreements with Novation for Teleflex’s Arrow® central venous access (CVC) products, Hudson RCI® and Gibeck® respiratory products, Sheridan® and Rusch® endotracheal tubes and Pleur-evac® chest drainage systems. The agreements begin January 1, 2012 and extend through December 31, 2014. Novation is the health care industry’s leading supply contracting company for the members of VHA, UHC and Provista.

“Teleflex is committed to working as a trusted resource for healthcare professionals as they work to provide high quality patient care.”

The agreements cover:

The full range of Arrow non-tunneled central venous access catheters, many of which are available in the ErgoPack™ System, a packaging system designed to support compliance with best practice and guidelines for catheter insertion. In addition, more than 30 studies and reviews support the ARROWg+ard™ catheter technology’s ability to reduce the incidence of central line-associated bloodstream infection (CLABSI).
Teleflex’s comprehensive portfolio of Hudson RCI and Gibeck respiratory products designed to meet patient needs throughout the Respiratory Pyramid of Care, including products for oxygen and aerosol therapy, humidification, filtration and non-invasive ventilation. Teleflex is an awarded supplier in three subcategories in the new Novation Airway Management Committed Portfolio—Ventilator Disposables, Routine Respiratory and Small Volume Nebulizers.
Teleflex’s full line of clinically differentiated endotracheal tubes, endobronchial tubes and intubation accessories. This includes the ISIS® HVT™, a convertible endotracheal tube that provides better access to best practices in airway management. The agreement also includes Teleflex’s Sheridan and Rusch brands, which demonstrate Teleflex’s continued commitment to design products that enhance procedural efficiency and promote patient safety during intubation.
The full line of Pleur-evac chest drainage products, the premier solution for thoracic, cardiovascular, trauma and critical care. The agreement also covers the Pleur-evac pneumonectomy unit, autotransfusion bags and thoracic catheters.

“We value our partnership with Novation and its VHA, UHC and Provista members across each of our product categories. We look forward to continuing to work with them under these new agreements,” said Benson F. Smith, Chairman, President and CEO, Teleflex Incorporated. “Teleflex is committed to working as a trusted resource for healthcare professionals as they work to provide high quality patient care.”

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,600 people worldwide and serves healthcare providers in more than 130 countries. Additional information about Teleflex can be obtained from the company's website at http://www.teleflex.com.

About Novation

Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and UHC, two national health care alliances, and 5,500 members of Provista, LLC, representing more than 30,000 sites. Novation provides alliance members sourcing and information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase approximately $40 billion in 2010.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Arrow, Hudson RCI, Gibeck, Rusch, Sheridan, ISIS, HVT, ErgoPack, ARROWg+ard, Pleur-evac and Teleflex are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.